OTC:MDBPF Medibank Private (MDBPF) Stock Price, News & Analysis → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free MDBPF Stock Alerts $2.22 0.00 (0.00%) (As of 05/6/2024 ET) Add Compare Share Share Today's Range$2.22▼$2.2250-Day Range$2.22▼$2.4552-Week Range$1.65▼$2.53VolumeN/AAverage Volume7,020 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartStock AnalysisAnalyst ForecastsChart Get Medibank Private alerts: Email Address Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. About Medibank PrivateMedibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands. Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.Read More MDBPF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MDBPF Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive MDBPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medibank Private and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTC SectorFinancial Services Industry Insurance - Specialty Sub-IndustryN/A Current SymbolOTC:MDBPF CUSIPN/A CIKN/A Webwww.medibank.com.au Phone61.3.8622.5780FaxN/AEmployees3,242Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. David Koczkar B.Com. (Age 51)MAICD, PGDipFinance, CEO, MD & Director Comp: $1.07MMr. Mark Rogers B.Sc.BEng (Hons), Group Lead - Chief Financial Officer & Group StrategyDr. Andrew Wilson FACHSEFRANZCP, M.M., MBBS, Group Chief Medical OfficerMr. Milosh MilisavljevicGroup Lead - Chief Customer OfficerMr. Peter KopanidisSenior Executive of Corporate FinanceMs. Felicia TrewinGroup Lead Data & TechnologyColette CampbellSenior Executive of Investor RelationsMs. Mei Ramsay B.A.L.L.B., L.L.M., Group Lead Trust, Legal & Compliance, Group General Counsel and Company SecretaryEmily RitchieSenior Executive of External AffairsMs. Kylie Bishop B.A.BA (Hons) Psy, MOrgPsych, Group Lead People, Spaces, Culture & SustainabilityMore ExecutivesKey CompetitorsBeazleyOTCMKTS:BZLYFLancashireOTCMKTS:LCSHFProtector Forsikring ASAOTCMKTS:PSKRFTrisura GroupOTCMKTS:TRRSF3i GroupOTCMKTS:TGOPFView All Competitors MDBPF Stock Analysis - Frequently Asked Questions Should I buy or sell Medibank Private stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medibank Private in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MDBPF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDBPF, but not buy additional shares or sell existing shares. View MDBPF analyst ratings or view top-rated stocks. How have MDBPF shares performed in 2024? Medibank Private's stock was trading at $1.65 at the beginning of the year. Since then, MDBPF stock has increased by 34.5% and is now trading at $2.22. View the best growth stocks for 2024 here. How do I buy shares of Medibank Private? Shares of MDBPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTC:MDBPF) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden replacement revealed?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medibank Private Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.